The New York Times reports:
A federal appeals court ruled late Wednesday that the abortion pill mifepristone could remain available, but the judges blocked the drug from being sent to patients through the mail and rolled back other steps the government had taken to ease access in recent years.
In its order, a three-judge panel for the Fifth Circuit partly overruled Judge Matthew J. Kacsmaryk [photo] of the Northern District of Texas, who last week declared that the FDA’s approval of mifepristone in 2000 was not valid, in essence saying that the drug should be pulled from the market.
The appellate court said its ruling would hold until the full case was heard on its merits. In its order, the appellate panel said the F.D.A.’s approval of mifepristone could stand because too much time had passed for the plaintiffs, a consortium of groups and doctors opposed to abortion, to challenge that decision.
Read the full article.
Breaking News: A federal appeals court said the abortion pill mifepristone could temporarily remain available with some restrictions. The judges said the ruling would hold until the full case is heard on appeal. https://t.co/xpROe6zBOw
— The New York Times (@nytimes) April 13, 2023